Jupiter Wellness, Inc. (JUPW)
Chart Events
Performance Outlook
| Previous Close | 4.1300 |
| Open | 4.0500 |
| Bid | 4.0000 x 1000 |
| Ask | 4.2000 x 1000 |
| Day's Range | 3.9600 - 4.1500 |
| 52 Week Range | 3.6000 - 8.8800 |
| Volume | 133,812 |
| Avg. Volume | 281,246 |
| Market Cap | 45.379M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- ACCESSWIRE
Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 for herpes cold sores.
- ACCESSWIRE
Jupiter Wellness Enters into Letter of Intent to Acquire JustCBD and its Affiliates
Accretive acquisition would add a profitable company with approximately $28 million of revenue in 2020 (unaudited)JUPITER, FL / ACCESSWIRE / April 20, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has signed a non-binding Letter of Intent with JustCBD and its affiliates to purchase 51% of JustCBD for $30 million in cash.
- ACCESSWIRE
Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products
JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has appointed Dr.
